
Alirocumab Injection: Uses, Dosage, Warnings, & Side Effects - Drugs.com
2024年3月13日 · Alirocumab is an injectable medicine that is given under your skin and may be used in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina); or to treat high blood chole
About PRALUENT | PRALUENT® (alirocumab) Injection
What is PRALUENT ® (alirocumab)? PRALUENT is an injectable prescription medicine used: in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina) requiring hospitalization.
Alirocumab - Wikipedia
Alirocumab, sold under the brand name Praluent, is a medication used as a second-line treatment for high cholesterol for adults whose cholesterol is not controlled by diet and statin treatment. It is a human monoclonal antibody that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors , and it was the first such agent ...
Alirocumab (subcutaneous route) - Mayo Clinic
2025年2月1日 · Alirocumab injection is used together with a proper diet and other medicines (eg, ezetimibe, statin medicine) to treat patients with primary hyperlipidemia (including heterozygous familial hypercholesterolemia) or with homozygous familial hypercholesterolemia (HoFH), who need additional lowering of their bad cholesterol (LDL).
Praluent (alirocumab) - Uses, Side Effects, and More - WebMD
2024年8月4日 · Praluent (alirocumab) is commonly used for the following conditions. To lower the risk of heart attack, stroke, and chest pain requiring hospitalization in people with heart disease
Administer PRALUENT by subcutaneous injection into the thigh, abdomen, or upper arm using a single-dose pre-filled pen or single-dose pre-filled syringe. Rotate the injection site with each...
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular ...
2015年4月16日 · Alirocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9), has been shown to reduce low-density lipoprotein (LDL) cholesterol levels in patients who...
Alirocumab Injection: MedlinePlus Drug Information
Alirocumab injection is in a class of medications called proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor monoclonal antibodies. It works by blocking the production of LDL cholesterol in the body therefore decreasing the amount of cholesterol that may build up …
Praluent Injection: Side Effects, Cost, Dosage, and More - Healthline
2022年9月4日 · Learn about side effects and more of Praluent (alirocumab), a prescription injection used to lower cholesterol and the risk of certain cardiovascular problems.
Alirocumab | Drugs | BNF | NICE
View alirocumab information, including dose, uses, side-effects, renal impairment, pregnancy, breast feeding and drug action.